| AERI Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the AERI shares outstanding history going back to 10/25/2013:
Also see: AERI Market Cap History AERI YTD Return |
AERI Shares Outstanding History — Aerie Pharmaceuticals Share Count Over Time
As of 10/28/2022 Aerie Pharmaceuticals has 49.42 million AERI shares outstanding. Investors often track the AERI shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows AERI share count trends over time, with 39 historical shares outstanding datapoints presented, dating back to 10/25/2013.
| AERI Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AERI Historical Shares Outstanding: +10.29% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AERI Stock Price Chart |
| About Aerie Pharmaceuticals Inc |
| Aerie Pharmaceuticals is a pharmaceutical company focused on the discovery, development and commercialization of ophthalmic therapies for the treatment of patients with eye diseases and conditions including open-angle glaucoma, dry eye, and diabetic macular edema. Rhopressa® is a once-daily eye drop designed to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Rocklatan® is a once-daily fixed-dose combination of Rhopressa® and latanoprost, a prescribed drug for the treatment of patients with open-angle glaucoma or ocular hypertension. Co. is developing AR-15512, an ophthalmic solution for the treatment of patients with dry eye disease. We show 39 historical shares outstanding datapoints in our coverage of AERI's shares outstanding history. Understanding the changing numbers of AERI shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like AERI versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching AERI by allowing them to research AERI shares outstanding history as well as any other stock in our coverage universe. |
| AERI Current Stock Quote |
Quotes delayed 20 minutes  Free AERI Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| AERI Share Performance |
| Shares Outstanding Peers |
| Aerie Pharmaceuticals (AERI) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
AEZS Shares Outstanding History AFIB Shares Outstanding History AGEN Shares Outstanding History AGIO Shares Outstanding History AGL Shares Outstanding History AGLE Shares Outstanding History AGN Shares Outstanding History AGPU Shares Outstanding History AGRX Shares Outstanding History AGTC Shares Outstanding History More Healthcare companies » |
AERI Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
